Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q72804492)
Watch
English
Additive hormonal therapy in women with advanced breast cancer
scientific article published on 01 February 1984
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
6229323
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6229323%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 October 2019
title
Additive hormonal therapy in women with advanced breast cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
6229323
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6229323%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 October 2019
main subject
oncology
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
author name string
J. N. Ingle
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
6229323
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6229323
retrieved
2 September 2023
language of work or name
English
0 references
publication date
1 February 1984
1 reference
stated in
Europe PubMed Central
PubMed ID
6229323
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6229323%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 October 2019
full work available at URL
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
published in
Cancer
1 reference
stated in
Europe PubMed Central
PubMed ID
6229323
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6229323%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 October 2019
volume
53
1 reference
stated in
Europe PubMed Central
PubMed ID
6229323
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6229323%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 October 2019
issue
3 Suppl
1 reference
stated in
Europe PubMed Central
PubMed ID
6229323
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6229323%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 October 2019
page(s)
766-777
1 reference
stated in
Europe PubMed Central
PubMed ID
6229323
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6229323%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 October 2019
cites work
Biochimica et Biophysica Acta
series ordinal
2
volume
560
page(s)
457
author name string
Edwards
publication date
1979
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Tamoxifen in advanced breast cancer
series ordinal
4
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels
series ordinal
5
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer
series ordinal
6
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
7
volume
64
page(s)
765
author name string
Fabian
publication date
1980
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Anti-oestrogen therapy of advanced mammary carcinoma
series ordinal
9
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Tamoxifen-induced remission in breast cancer by escalating the dose to 40 mg daily after progression on 20 mg daily: a case report and review of the literature
series ordinal
10
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
11
volume
66
page(s)
1445
author name string
Stewart
publication date
1982
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.
series ordinal
14
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Preliminary trial of aminoglutethimide in breast cancer
series ordinal
15
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma
series ordinal
16
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Suppression of estrogens with Aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: A review
series ordinal
17
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*
series ordinal
18
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Adrenal Suppression with Aminoglutethimide. I. Differential Effects of Aminoglutethimide on Glucocorticoid Metabolism as a Rationale for Use of Hydrocortisone12
series ordinal
23
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
British Journal of Cancer
series ordinal
25
volume
44
page(s)
285
author name string
Harris
publication date
1981
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Serum Aminoglutethimide Levels: Studies of Serum Half-Life, Clearance, and Patient Compliance
series ordinal
26
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Polymorphically acetylated aminoglutethimide in humans
series ordinal
27
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapy
series ordinal
28
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer
series ordinal
29
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
30
volume
62
page(s)
1581
author name string
Lawrence
publication date
1978
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer chemotherapy reports
series ordinal
34
volume
41
page(s)
1
author name string
Cooperative Breast Cancer Group
publication date
1964
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
High-Dose Medroxyprogesterone Acetate (MPA) Treatment in Advanced Breast Cancer. A Review
series ordinal
36
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
38
volume
62
page(s)
499
author name string
Pannuti
publication date
1978
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
High Dose Medroxyprogesterone-Acetate Treatment in Advanced Mammary Carcinoma: A Phase II Investigation
series ordinal
39
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
High Dose Medroxyprogesterone Acetate (MPA) Treatment in Metastatic Carcinoma of the Breast: A Dose-Response Evaluation
series ordinal
40
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer
series ordinal
41
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Oral high-dose medroxyprogesterone acetate (MAP) in treatment of advanced breast cancer. A preliminary report of clinical and experimental studies
series ordinal
43
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology
series ordinal
44
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Norethisterone acetate (SH420) in advanced breast cancer
series ordinal
45
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Norethisterone acetate in the treatment of advanced breast cancer
series ordinal
46
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Progestin therapy in advanced breast cancer: megestrol acetate--an evaluation of 160 treated cases
series ordinal
48
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Danazol
series ordinal
49
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Danazol in the treatment of mammary dysplasia
series ordinal
50
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Danazol
series ordinal
51
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Danazol: endocrine pharmacology and therapeutic applications
series ordinal
52
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Danazol therapy in hormone-sensitive mammary carcinoma
series ordinal
53
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
54
volume
64
page(s)
1073
author name string
Coombes
publication date
1980
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Yale Journal of Biology and Medicine
series ordinal
55
volume
55
page(s)
27
author name string
Corbin
publication date
1982
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
COUNCIL ON DRUGS
series ordinal
57
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
COMBINED ESTROGENIC AND ANDROGENIC HORMONE THERAPY IN ADVANCED BREAST CANCER
series ordinal
59
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Disseminated breast cancer: Evaluation of hormonal therapy utilizing stilbestrol and medrogestone (AY-62022) singly and in combination
series ordinal
60
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer
series ordinal
61
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
63
volume
65
page(s)
179
author name string
Beex
publication date
1981
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
64
volume
64
page(s)
117
author name string
Westerberg
publication date
1980
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial
series ordinal
65
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Comparison of tamoxifen and hypophysectomy in breast cancer treatment
series ordinal
67
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer
series ordinal
68
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer
series ordinal
72
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
76
volume
60
page(s)
1445
author name string
Manni
publication date
1976
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
77
volume
60
page(s)
1431
author name string
Lerner
publication date
1976
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
78
volume
60
page(s)
1437
author name string
Morgan
publication date
1976
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
79
volume
60
page(s)
1463
author name string
Heuson
publication date
1976
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
80
volume
64
page(s)
787
author name string
Pritchard
publication date
1980
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
81
volume
64
page(s)
779
author name string
Manni
publication date
1980
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
83
volume
66
page(s)
1867
author name string
Kalman
publication date
1982
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Cancer Treatment Reports
series ordinal
84
volume
65
page(s)
728
author name string
Wada
publication date
1981
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Resistance of the ovary to blockade of aromatization with aminoglutethimide
series ordinal
85
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer
series ordinal
86
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
reference URL
https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C766::AID-CNCR2820531327%3E3.0.CO;2-H
retrieved
2 September 2023
Identifiers
DOI
10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
1 reference
stated in
Europe PubMed Central
PubMed ID
6229323
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6229323%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 October 2019
PubMed ID
6229323
1 reference
stated in
Europe PubMed Central
PubMed ID
6229323
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6229323%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
